Alx Oncology Holdings (ALXO) Change in Acquisitions & Divestments (2022 - 2026)

Alx Oncology Holdings has reported Change in Acquisitions & Divestments for 5 years, with the latest figure at $19.5 million in Q1 2026.

• Quarterly Change in Acquisitions & Divestments fell 55.15% year-over-year to $19.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $110.4 million (down 38.55% YoY) and the FY2025 annual result came in at $134.4 million, down 30.77% from the prior year.
• Change in Acquisitions & Divestments grew to $19.5 million in Q1 2026 per ALXO's latest filing, from $17.3 million in the prior quarter.
• Over five years, Change in Acquisitions & Divestments peaked at $115.2 million in Q1 2023 and troughed at $17.3 million in Q4 2025.
• A 5-year average of $50.9 million and a median of $50.5 million in 2022 frame the typical range for Change in Acquisitions & Divestments.
• The sharpest annual moves came in 2023 and 2026: Change in Acquisitions & Divestments climbed 27.53% in 2023, then slumped 55.15% in 2026.
• Over 5 years, Change in Acquisitions & Divestments stood at $72.3 million in 2022, then slipped by 19.1% to $58.5 million in 2023, then sank by 35.57% to $37.7 million in 2024, then slumped by 54.21% to $17.3 million in 2025, then rose by 13.0% to $19.5 million in 2026.
• According to Business Quant data, Change in Acquisitions & Divestments over the past three periods registered $19.5 million, $17.3 million, and $25.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.